Global Hemophilia Treatment Market was worth US$ 11,474.3 million, and it is Predicted to Grow at a CAGR of 5.9% over the Forecast Period 2019-2027

-
Hemophilia Treatment
Hemophilia Treatment

Hemophilia is a genetic bleeding disorder in which a person's clotting factor, factor VIII, is absent or has low amounts. Clotting factors are proteins that work with blood platelets to aid clotting. There are about 13 different types of clotting factors. Hemophilia is divided into three types: A, B, and C. Hemophilia A is the most frequent type, and it is caused by a factor VIII deficiency. Hemophilia B is caused by a factor IX deficiency, while Hemophilia C is caused by a factor XI deficiency.

Over the projected period, new product launches by industry players in the Hemophilia Treatment Market are expected to fuel market growth. For example, the European Commission granted Novo Nordisk marketing permission for 'Esperoct' in Europe in June 2019. Turoctocog alfa pegol, N8-GP, is a brand name for turoctocog alfa pegol, a drug used to treat hemophilia A in adolescents and adults (congenital factor VIII deficiency).

The global Hemophilia Treatment Market is predicted to develop due to an increase in the number of cases with bleeding disorders. Additionally, rising government activities to raise public awareness regarding hemophilia treatment are likely to drive market expansion throughout the projection period. The National Bleeding Authority (NBA), for example, funds AHCDO (Australian Hemophilia Center Directors' Organization) for haemophilia A (Factor VIII Deficiency) treatment and control in Australia. 

Because of the increased frequency of hemophilia or bleeding disorders, the global Hemophilia Treatment Market is predicted to grow significantly.  According to the Australian Bleeding Disorders Registry, there were approximately 4,941 patients with common inherited bleeding disorders in Australia in 2015, with 2,301 patients diagnosed with hemophilia A and 548 patients diagnosed with hemophilia B. Over the projected period, rising hemophilia prevalence is expected to boost demand for hemophilia treatment. Furthermore, throughout the forecast period, rising demand for effective medicines for the treatment of factor VIII insufficiency from emerging economies such as India is expected to boost market expansion. According to 2017 figures from the World Federation of Hemophilia, around 18,353 people in India were diagnosed with hemophilia in 2016.

Comments

Post a Comment

Popular posts from this blog

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Tissue Banking Market Offering Deep Insight Related to Growth Trends Until 2028

-
Image
Tissue Banking Market The process of gathering, processing, storing, and distributing transplantable human tissues is known as tissue banking. Tissues taken from the human body are utilised to repair or replace sick or missing tissues in the human body. Cornea, bones, fascia, heart valves, skin, cartilage, joints, tendons, and duramater from human cadavers are among the most commonly extracted and used tissues. The global Tissue Banking Market was valued at US$ 1.04 billion in 2017 and is predicted to grow at a CAGR of 10.8 percent between 2018 and 2026. The global tissue banking market is divided into five regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Due to increased government assistance, the European tissue banking market is likely to produce a large revenue share during the forecast period. For example, NHS Blood and Transplant (NHSBT) is a special health authority in the United Kingdom that is responsible for blood, organ, and tissue d...
Read more